Channel Avatar

ISAC / APUA @UC5-ErPKUtbfllpAXj8_JrtQ@youtube.com

1.06K subscribers - no pronouns set

Established in 1961, ISAC is a global non-profit organisatio


01:43:01
Antifungal resistance in Candida and Aspergillus: is the honeymoon over?
01:32:56
One health aspects of AMR and infections in Asia
01:23:07
Rapid diagnostics and strain typing in the era of antimicrobial resistance | ISAC Webinar
01:23:47
Ortho spinal infections in the era of increasing AMR | ISAC Webinar
03:56
33rd International Congress of Antimicrobial Chemotherapy (ICC)
26:11
Carbapenem Resistant Enterobacterales (CRE) treatment: do multinational observational studies help?
01:59:36
Phage pharmacology & therapy | ISAC Webinar
01:59
Welcome to ISAC 2024
01:50:09
H5N1 Avian Influenza: the path from panzootic to pandemic | ISAC Webinar
00:17
NEW Antibiotic Summary Cards
01:28:12
Zero by 2023: One Health perspectives of rabies elimination | ISAC Webinar
22:29
Aspergillus in the ICU: when opportunity comes knocking | 32nd ICC
01:53:54
Beyond the pill: Transformative approaches to combat antimicrobial resistance
48:35
Membrane lipid remodelling confers polymyxin resistance in Gram-negative bacteria
30:13
Antibiotic allergy - a risk worth taking? | 32nd ICC
29:27
Current management of Staphylococcus aureus | 32nd ICC
52:08
AMR Control Under One Health | 32nd ICC
01:34:27
Viral respiratory tract infections: superinfections | ISAC WEBINAR
31:08
New therapeutic developments for the treatment of fungal infections | 32nd ICC
01:29:18
The benefits of routine-based sequencing of pathogens | Webinar
45:39
From HIV to COVID-19 & beyond: the role of antivirals in responding to pandemics | 32nd ICC
54:05
Phages – from personalised therapy to regulatory approval | 32nd ICC
45:56
Treatment of multidrug resistant Pseudomonas aeruginosa infections | 32nd ICC
46:52
Microbial Theranostics - a Resistance Combatting Strategy | 32nd ICC
01:09:26
Journey into the anti-infective field: academic, clinical and industry perspectives
56:38
Introduction to adaptive clinical trial design
01:35:16
Dissemination of viral infections during mass gatherings
02:12:04
COVID-19: revaccination and variant vaccines
01:04:48
Antimicrobial Pharmacometrics: Mathematical Models for Antimicrobial Research and Development
01:08:06
Monkeypox: a new human threat?
01:22:35
The fight against antimicrobial resistance: a luta continua
02:01:26
Multidrug resistance (MDR) Gram-negative bacilli
01:32:25
Hot topics in skin, bone and joint infections
01:51
ISAC Academy website launch
01:03:44
Clinical Trials Targeting Antimicrobial Resistance
01:02:58
Antimicrobial therapy in biofilm-associated infections
55:06
New Roles of beta-lactamase enzymes
04:28:36
Hot topics on infections in critical care
00:29
ISAC / APUA Newsletter: 100 years of fighting infectious diseases & antimicrobial resistance
00:14
APCCMI 2021
55:29
100 years of fighting ID and AMR: ISAC and APUA Anniversary Webinar
02:18
International Congress of Antimicrobial Chemotherapy (ICC) 2022
03:12
Dr Stephen Lerner
03:10
Prof. Raphael Saginur, Canada
02:21
Prof. Kazuhiro Tateda, Japan
01:17
Prof. Heiman Wertheim, the Netherlands
02:06:03
What is Long COVID?
02:06:16
Regional & National MRSA Surveillance Programs Webinar
00:38
What is long COVID-19?
03:22:29
COVID-19: Around the World in 80+ Minutes Webinar
01:22:22
Rapid diagnostics & biomarkers at the heart of patient management
01:18:42
COVID 19 Variants Webinar
01:42:35
COVID 19 Vaccines
02:33
Prof. Robin Patel, USA
03:35
Prof. Stefania Stefani, Italy
05:10
Prof. Jean Marc Rolain, France
05:16
Prof. Gabriel Levy Hara, Argentina
01:26
Cristina Larkin, USA
01:26
Dr Fred Tenover, USA
02:21
Dr Paul Tambyah, Singapore